Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD | Haematologica
![Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention | Science Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention | Science](https://www.science.org/cms/asset/e5d79d60-4484-4bf3-8756-d7d8fea7c542/369_abb9601_fa.gif)
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention | Science
![SciELO - Brasil - Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset SciELO - Brasil - Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset](https://minio.scielo.br/documentstore/1980-5322/BFSm5JqQczL4GWnkZNqD8Tn/10100b74ef0706080464af2c31e12dddb59956fa.jpg)
SciELO - Brasil - Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset
Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia | Haematologica
![Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia | American Society of Clinical Oncology Educational Book Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2018/edbk.2018.38/edbk_200689/20180622/images/large/edbk_200689_table2.jpeg)
Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia | American Society of Clinical Oncology Educational Book
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
![Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study | Journal of Clinical Oncology Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2019/jco.2019.37.issue-15/jco.18.01600/20190507/images/large/jco.18.01600t2.jpeg)